
cultivate(MD) Capital Funds Portfolio Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface
Grand Rapids, Mich., October 23, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies,